ホーム › 膠腫 › ペンシルベニア › Philadelphia
Philadelphia、PAにおける膠腫の臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、膠腫に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
被験者募集中第1/2相
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25マイル先
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
被験者募集中第2相
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
被験者募集中第1/2相
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
被験者募集中早期第1相
- The Children s Hospital of Philadelphia, Philadelphia
Targeted Pediatric High-Grade Glioma Therapy
被験者募集中観察研究
- Children's Hospital of Philadelphia, Philadelphia
Study of Olutasidenib and Temozolomide in HGG
被験者募集中第2相
- Children's Hospital of Philadelphia, Philadelphia
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
被験者募集中第3相
- Thomas Jefferson University Hospital, Philadelphia
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
被験者募集中第2相
- Children's Hospital of Philadelphia, Philadelphia
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
被験者募集中第1相
- Children's Hospital of Philadelphia, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
被験者募集中第2相
- Thomas Jefferson University, Philadelphia
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
被験者募集中第1/2相
- Children's Hospital of Philadelphia, Philadelphia
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
被験者募集中早期第1相健康なボランティア歓迎
- Children's Hospital of Philadelphia, Philadelphia
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
被験者募集中第2相
- Children's Hospital of Philadelphia, Philadelphia
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
被験者募集中早期第1相
- Children's Hospital of Philadelphia, Philadelphia
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
被験者募集中第2相
- University of Pennsylvania, Philadelphia
18F-Fluciclovine PET-MRI in High-grade Glioma
被験者募集中早期第1相
- Children's Hospital of Philadelphia, Philadelphia
他の都市における膠腫の試験
- New York City, NY25件の研究
- Houston, TX23件の研究
- Boston, MA20件の研究
- Washington, DC19件の研究
- Columbus, OH15件の研究
- Miami, FL15件の研究
- San Francisco, CA14件の研究
- Chicago, IL13件の研究
- Durham, NC12件の研究
- Seattle, WA11件の研究
- St. Louis, MO10件の研究
- Aurora, CO10件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 大腸癌44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。